Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria

Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria

Show other versions (1)

Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the replacement of older erythrocytes with low G6PD activity...

Full description

Bibliographic Details
Main Authors:	Benedikt Ley, Mohammad Shafiul Alam, Ari Winasti Satyagraha, Ching Swe Phru, Kamala Thriemer, Dagimawie Tadesse, Tamiru Shibiru, Asrat Hailu, Mohammad Golam Kibria, Mohammad Sharif Hossain, Hisni Rahmat, Jeanne R. Poespoprodjo, Wasif Ali Khan, Julie A. Simpson, Ric N. Price
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-05-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094517/?tool=EBI

Similar Items

Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria
by: Ley, Benedikt, et al.

Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria.
by: Benedikt Ley, et al.
Published: (2022-05-01)

Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.
by: Mohammad Shafiul Alam, et al.
Published: (2018-01-01)

Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh.
by: Benedikt Ley, et al.
Published: (2021-04-01)

Variation in glucose-6-phosphate dehydrogenase activity following acute malaria
by: Ley, B, et al.
Published: (2022)

Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh.
by: Benedikt Ley, et al.
Published: (2020-09-01)

G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study.
by: Benedikt Ley, et al.
Published: (2016-01-01)

Precarity at the Margins of Malaria Control in the Chittagong Hill Tracts in Bangladesh: A Mixed-Methods Study
by: Mohammad Abdul Matin, et al.
Published: (2020-10-01)

Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh
by: Tiffany Huwe, et al.
Published: (2022-07-01)

Spectrophotometry assays to determine G6PD activity from Trinity Biotech and Pointe Scientific G6PD show good correlation
by: Mohammad Shafiul Alam, et al.
Published: (2018-12-01)

Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
by: Tamiru S. Degaga, et al.
Published: (2020-06-01)

Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh
by: Nora Engel, et al.
Published: (2021-05-01)

Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas—a randomized controlled trial (PRIMA)
by: Kamala Thriemer, et al.
Published: (2022-05-01)

Barriers to routine G6PD testing prior to treatment with primaquine
by: Benedikt Ley, et al.
Published: (2017-08-01)

Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-Analysis
by: Daniel A. Pfeffer, et al.
Published: (2022-09-01)

Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity
by: Alam, MS, et al.
Published: (2018)

A novel generation of hemozoin based malaria diagnostics show promising performance
by: Benedikt Ley, et al.
Published: (2020-05-01)

Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
by: Benedikt Ley, et al.
Published: (2019-12-01)

Correction: Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
by: Daniel A Pfeffer, et al.
Published: (2020-07-01)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
by: Walter R J Taylor, et al.
Published: (2023-09-01)

Field assessment of the operating procedures of a semi-quantitative G6PD Biosensor to improve repeatability of routine testing.
by: Arkasha Sadhewa, et al.
Published: (2024-01-01)

Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
by: Daniel A Pfeffer, et al.
Published: (2020-05-01)

Antibody and cytokine levels in visceral leishmaniasis patients with varied parasitemia before, during, and after treatment in patients admitted to Arba Minch General Hospital, southern Ethiopia.
by: Dagimawie Tadesse, et al.
Published: (2021-08-01)

Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.
by: Kamala Thriemer, et al.
Published: (2021-04-01)

Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: analysis of clinical trial, cross-sectional and case–control data from Bangladesh
by: Ley, B, et al.
Published: (2021)

An Optimized Real-Time qPCR Method for the Effective Detection of Human Malaria Infections
by: Saiful Arefeen Sazed, et al.
Published: (2021-04-01)

Epidemiology of visceral leishmaniasis in Shebelle Zone of Somali Region, eastern Ethiopia
by: Getachew Alebie, et al.
Published: (2019-05-01)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
by: Annisa Rahmalia, et al.
Published: (2023-05-01)

Methods for the field evaluation of quantitative G6PD diagnostics: a review
by: Benedikt Ley, et al.
Published: (2017-09-01)

A Case of <i>Plasmodium malariae</i> in Bangladesh: A Representation of the Suboptimal Performance of Rapid Diagnostic Approaches in Malaria Elimination Settings
by: Fatema Tuj Johora, et al.
Published: (2022-09-01)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
by: Kamala Thriemer, et al.
Published: (2020-11-01)

A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
by: Arkasha Sadhewa, et al.
Published: (2023-04-01)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
by: Poespoprodjo, Jeanne Rini, et al.
Published: (2022)

Composition of Anopheles species and bionomic characteristics over the peak malaria transmission season in Bandarban, Bangladesh
by: Hasan Mohammad Al-Amin, et al.
Published: (2023-06-01)

Human behaviour directs household-level exposure to malaria vectors in Bandarban, Bangladesh
by: Matthew A. Aubourg, et al.
Published: (2022-11-01)

Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia
by: Bipin Adhikari, et al.
Published: (2022-10-01)

Analysis of erroneous data entries in paper based and electronic data collection
by: Benedikt Ley, et al.
Published: (2019-08-01)

The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
by: Kamala Thriemer, et al.
Published: (2023-09-01)

Glucose-6-Phosphate Dehydrogenase (G6PD) Measurement Using Biosensors by Community-Based Village Malaria Workers and Hospital Laboratory Staff in Cambodia: A Quantitative Study
by: Bipin Adhikari, et al.
Published: (2023-03-01)

Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh
by: Ley, B, et al.
Published: (2020)